VC firm emerges to boost Austrian biotech scene that’s ‘ready to break out’
When Christopher Trummer tried raising money for his molecular glue degrader startup, he struggled to find VC support in his native Austria. The company, Celeris Therapeutics, had ...
endpoints.news